Bruker (BRKR) Short-term Investments (2014 - 2026)

Bruker has reported Short-term Investments for 12 years, with the latest figure at $28.2 million in Q1 2026.

• For the quarter ending Q1 2026, Short-term Investments rose 256.96% year-over-year to $28.2 million; the trailing twelve-month figure through Mar 2026 stood at $28.2 million (up 256.96% YoY), and the FY2025 full-year result was $23.8 million, up 213.16% from the prior year.
• Short-term Investments for Q1 2026 stood at $28.2 million, up from $23.8 million in the prior quarter.
• The five-year high for Short-term Investments was $100.0 million in Q1 2022, with the low at $30.5 in Q3 2023.
• Historically, Short-term Investments has averaged $25.1 million across 5 years, with a median of $23.8 million in 2025.
• Annual changes were most pronounced in 2024 — Short-term Investments surged 112458916.39% — and 2025, when it slumped 88.63%.
• Bruker's Short-term Investments stood at $14.8 million in 2022, then fell by 18.92% to $12.0 million in 2023, then sank by 36.67% to $7.6 million in 2024, then soared by 213.16% to $23.8 million in 2025, then grew by 18.49% to $28.2 million in 2026.
• The last three Short-term Investments figures came in at $28.2 million (Q1 2026), $23.8 million (Q4 2025), and $3.9 million (Q3 2025), per Business Quant data.